GRAIL, Inc. Investing Cash Flow
GRAIL, Inc. (GRAL) reported Investing Cash Flow of -$140.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- GRAIL, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$46.58M, a 166.19% decline year-over-year.
- GRAIL, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$93.44M, a 739.50% decline year-over-year.
- GRAIL, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$236.70M.
- GRAIL, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $66.67M.
- GRAIL, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$85.05M.
- GRAIL, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$551.01M.
- GRAIL, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$12.89M.
- GRAIL, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$22.86M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$46.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$140.01M 10-Q · filed 2026-08-06 | -$376.72M derived: sum of 3 quarters · filed 2026-08-06 | -$310.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$93.44M 10-Q · filed 2026-05-07 | -$330.14M derived: sum of 2 quarters · filed 2026-05-07 | -$263.47M derived: sum of 3 quarters · filed 2026-05-07 | -$193.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$236.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$170.03M derived: sum of 2 quarters · filed 2026-03-12 | -$99.66M derived: sum of 3 quarters · filed 2026-08-06 | -$85.05M 10-K · filed 2026-03-12 |
| 2025-09-30 | $66.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $137.04M derived: sum of 2 quarters · filed 2026-08-06 | $151.65M 10-Q · filed 2025-11-13 | -$394.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $70.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $84.98M 10-Q · filed 2026-08-06 | -$461.13M derived: sum of 3 quarters · filed 2026-08-06 | -$462.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $14.61M 10-Q · filed 2026-05-07 | -$531.50M derived: sum of 2 quarters · filed 2026-05-07 | -$532.47M derived: sum of 3 quarters · filed 2026-05-07 | -$533.85M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$546.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$547.08M derived: sum of 2 quarters · filed 2026-03-12 | -$548.46M derived: sum of 3 quarters · filed 2026-03-12 | -$551.01M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$971.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.36M derived: sum of 2 quarters · filed 2025-11-13 | -$4.91M 10-Q · filed 2025-11-13 | -$8.80M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.93M 10-Q · filed 2025-08-13 | -$7.83M derived: sum of 3 quarters · filed 2026-03-12 | -$10.90M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$2.55M 10-Q · filed 2025-05-14 | -$6.44M derived: sum of 2 quarters · filed 2026-03-12 | -$9.51M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$6.96M derived: sum of 2 quarters · filed 2026-03-12 | -$12.89M 10-K · filed 2025-03-05 | |
| 2023-10-01 | -$3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$8.99M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$5.92M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | -$22.86M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |